share_log

Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket

Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket

为什么NeuroBo Pharmicals的交易价格上涨了约55%;以下是25只股票盘前走势
Benzinga Real-time News ·  2022/09/15 07:56
Gainers
获胜者
NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) rose 54.6% to $26.07 in pre-market trading after the company entered into an exclusive license agreement with Dong-A. Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) shares rose 28.6% to $0.2765 in pre-market trading. Sonnet BioTherapeutics, last month, posted a Q3 loss of $0.13 per share. Aditxt, Inc. (NASDAQ:ADTX) rose 24.9% to $14.28 in pre-market trading. Aditxt announced a 1-for-50 reverse stock split effective on September 14, 2022. Fast Radius, Inc. (NASDAQ:FSRD) rose 19.4% to $0.6260 in pre-market trading. The company, last month, posted upbeat quarterly results. Addentax Group Corp. (NASDAQ:ATXG) shares rose 16.3% to $5.56 in pre-market trading after jumping...
NeuroBo Pharmicals, Inc.(纳斯达克股票代码:NRBO)与Dong-A签订独家许可协议后,在盘前交易中上涨54.6%,至26.07美元。 Sonnet BioTherapeut...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发